ScientistLive

28/05/2026

Sino Biological Inc. cell-free protein synthesis used in study

Read more: https://bit.ly/49rmYK4

The protein design study aimed to validate AI-designed proteins with improved activity, stability and multifunctionality

27/05/2026

New range of cell lines from Amsbio

Read more: https://bit.ly/43whZnP

The addition offers over 1,000 cell lines covering a range of tumours and tissues

26/05/2026

Partnership to accelerate drug development

Read more: https://bit.ly/4uCQAg0

AI/ML predictive models will be integrated into an electronic notebook to support workflows

21/05/2026

📣 In a recent announcement, it was stated that several OEM open-frame degasser modules on the market will soon be obsolete...

🧠 As a result, Biotech Fluidics is introducing direct replacements for all these modules based on upgraded vacuum technology, enabling companies that use them to continue supplying products while avoiding the prohibitive costs of a total system redesign

🔗https://bit.ly/3PtFZ7V

21/05/2026

Study finds potential new bone cancer treatment

Read more: https://bit.ly/4dDfNzw

Osteosarcoma is an aggressive bone cancer characterised by high rate of recurrence and metastasis. It is the most common primary bone cancer in children, adolescents and young adults. Symptoms include chronic bone pain, swelling and limping. Osteosarcoma cells often remain locked in an immature deve...

20/05/2026

New assay to lead to safer chemotherapy

Read more: https://bit.ly/4ut4aCK

The assay uses genetic insights to identify patients with dihydropyrimidine dehydrogenase deficiency

19/05/2026

🔬 Sino Biological has launched the XPressMAX Cell-Free Protein Synthesis Kit

🧠 The solution is designed to supercharge AI-driven high-throughput screening pipelines for antibody drug discovery

🔗https://bit.ly/4uj23B3

19/05/2026

Sino Biological Inc. launches cell-free protein synthesis kit

Read more: https://bit.ly/4uj23B3

The solution is designed to supercharge AI-driven high-throughput screening pipelines for antibody drug discovery

18/05/2026

Qureight imaging used in SSc clinical trial

Read more: https://bit.ly/3PmezAN

Imaging CRO Qureight will use its end-to-end imaging technology and services in a clinical trial analysing diffuse cutaneous Systemic Sclerosis (dcSSc). SSc is a complex disease characterised by fibrosis, vasculopathy and inflammation in the lungs, skin and other vital organs. It is associated with....

15/05/2026

🧬 Sophia Genetics is collaborating with Synnovis, a UK-based pathology provider, to bring liquid biopsy testing to lung and breast cancer patients across the UK as part of NHS England’s ‘blood test-first’ program.

🔬 The new blood test can help fast-track cancer patients to receive targeted therapy up to two weeks earlier, while helping some avoid further tests and invasive treatments.

🔗https://bit.ly/4uPwoHA